首页> 外国专利> Compositions for treating Escherichia coli urinary tract infections

Compositions for treating Escherichia coli urinary tract infections

机译：用于治疗大肠杆菌泌尿道感染的组合物

页面导航

摘要
著录项
相似文献

摘要

Compositions and methods for diagnosing, treating and preventing recurrent E. coli urinary tract infections relate to the detection and use of globosides, such as disialosyl galactosyl-globoside (DSGG) and sialosyl galactosyl-globoside (SGG), and stabilized forms thereof, such as those wherein sialic acid is replaced by KDN

机译：诊断，治疗和预防复发性 E的组合物和方法。大肠杆菌泌尿道感染涉及球蛋白的检测和使用，例如二唾液酸半乳糖基-球蛋白（DSGG）和唾液酸半乳糖基-球蛋白（SGG），以及它们的稳定形式，例如其中唾液酸被KDN取代的那些 展开▼

著录项

公开/公告号US6432681B1

专利类型

公开/公告日2002-08-13

原文格式PDF

申请/专利权人 THE REGENTS OF THE UNIVERSITY OF WASHINGTON;THE BIOMEMBRANE INSTITUTE;
展开▼

申请/专利号US19990350374

发明设计人 ANN STAPLETON;EDWARD NUDELMAN;WALTER E. STAMM;SEN-ITIROH HAKOMORI;
展开▼

申请日1999-07-09

分类号C12P190/00;C12P194/40;

国家 US

入库时间 2022-08-22 00:50:16

相似文献

专利

外文文献

中文文献

1. 一种治疗复发性泌尿道感染的中药组合物及其制备方法 [P] . 中国专利： CN113018396A . 2021-06-25

2. 用于治疗家禽大肠杆菌感染的中药组合物 [P] . 中国专利： CN103768271A . 2014-05-07

3. Method for determining susceptibility to Escherichia coli urinary tract infections, method for diagnosing secretors and nonsecretors, and method and medicament for preventing Escherichia coli urinary tract infections [P] . 美国专利： US6130205A . 2000-10-10

机译：确定对大肠杆菌尿路感染的易感性的方法，诊断分泌物和非分泌物的方法，以及预防大肠杆菌尿路感染的方法和药物

4. A PHARMACEUTICAL COMPOSITION INHIBITING FIMH OF UROPATHOGENIC ESCHERICHIA COLI FOR PREVENTION OF URINARY TRACT INFECTIONS [P] . IN2015CH01797A . 2016-10-07

机译：抑制尿路致病性大肠埃希菌的FiMH的药物组合物，用于预防尿路感染

5. Diagnostic unit of urinary tract infections and identification of Escherichia coli [P] . BR7401251U . 1995-01-10

机译：尿路感染诊断单位和大肠杆菌的鉴定

1. Integron frequency of Escherichia coli strains from patients with urinary tract infection in Southwest of Iran [J] . Miaad K. Alkhudhairy, Morteza Saki, Sakineh Seyed-Mohammadi, 急性病杂志（英文版） . 2019,第003期

2. Integron frequency of Escherichia coli strains from patients with urinary tract infection in Southwest of Iran [J] . Miaad K.Alkhudhairy, Morteza Saki, Sakineh Seyed-Mohammadi, 急性病杂志(英文版) . 2019,第003期

3. Effect of "Fuzheng Qingre Tonglin" prescription on rats with complicated urinary tract infection caused by ESBLs-producing Escherichia coli [J] . Fan Liu, Hong-Wei Su, Tian-Wen He, 海南医科大学学报（英文版） . 2019,第019期

4. Antibiotic Resistance Patterns of Escherichia coli in Pediatric Urinary Tract Infections for the years 2001 -2008 [C] . Kim Jun-Mo, Kim Tae-Hee, Shin Hee-Bong International Congress of Chemotherapy and Infection . 2009

5. Antimicrobial resistance and selected beta-lactam resistance genes in Escherichia coli from canine urinary tract infections. [D] . Khashayar, Behrouz. 2010

6. Clonal Composition of Escherichia coli Causing Community-Acquired Urinary Tract Infections in the State of Rio de Janeiro Brazil [O] . Rubens C.S. Dias, Denise V. Marangoni, Sherry P. Smith, -1

7. Urinary tract-derived Escherichia coli resistant to co-trimoxazole in Japan, where the drug is seldom used for treating acute urinary tract infections [O] . S. Ishihara 2002

1. Prevalence,serotyping and drug susceptibility patterns of Escherichia coli isolates from kidney transplanted patients with urinary tract infections [J] . Atefeh Najafi Khah ,Mojdeh Hakemi-Vala ,Shiva Samavat . 世界生物化学杂志：英文版（电子版） . 2020,第3期

2. Predictive factors for early clinical response in community-onset Escherichia coli urinary tract infection and effects of initial antibiotic treatment on early clinical response [J] . Young Jun Kim ,Jeong-Mi Lee ,Jae-Hoon Lee . 世界临床病例杂志 . 2020,第019期

3. 活用《伤寒杂病论》经方治疗泌尿道感染 [C] . 王怡 . 中华中医药学会第二十六次肾病分会学术交流会议 . 2013

4. 两性霉素B纳米复合物的制备及其用于隐球菌感染的治疗研究 [A] . 彭丽 . 2019